{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:38:34Z","timestamp":1791261514461,"version":"4.1.0"},"reference-count":103,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1681\/asn.2017070781","type":"journal-article","created":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T09:30:19Z","timestamp":1512034219000},"page":"362-375","source":"Crossref","is-referenced-by-count":71,"title":["Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology"],"prefix":"10.1681","volume":"29","clinical-trial-number":[{"clinical-trial-number":"nct00752479","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02012153","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02409940","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00658073","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00734396","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01429038","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00733876","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01602328","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01843387","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02166489","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01840540","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00698191","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01741857","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01539902","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02012153","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02057965","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02387151","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02490020","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02492308","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02409940","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02561767","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02563366","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02563340","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02565459","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01429038","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00659620","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01275612","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03015623","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02195323","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02585622","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02266394","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00659217","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02633163","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01429038","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01602328","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Norberto","family":"Perico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Casiraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,11,30]]},"reference":[{"key":"B1-20230120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0301-472X(01)00769-X","article-title":"Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.","volume":"30","author":"Bartholomew","year":"2002","journal-title":"Exp Hematol"},{"key":"B2-20230120","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.4049\/jimmunol.181.6.3933","article-title":"Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells.","volume":"181","author":"Casiraghi","year":"2008","journal-title":"J Immunol"},{"key":"B3-20230120","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1600-6143.2009.02721.x","article-title":"Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance.","volume":"9","author":"Ge","year":"2009","journal-title":"Am J Transplant"},{"key":"B4-20230120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trim.2008.08.004","article-title":"Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate.","volume":"20","author":"Popp","year":"2008","journal-title":"Transpl Immunol"},{"key":"B5-20230120","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaut.2009.01.003","article-title":"Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia.","volume":"32","author":"Solari","year":"2009","journal-title":"J Autoimmun"},{"key":"B6-20230120","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1111\/j.1600-6143.2012.04115.x","article-title":"Localization of mesenchymal stromal cells dictates their immune or proinflammatory effects in kidney transplantation.","volume":"12","author":"Casiraghi","year":"2012","journal-title":"Am J Transplant"},{"key":"B7-20230120","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrneph.2016.7","article-title":"Mesenchymal stromal cells in renal transplantation: Opportunities and challenges.","volume":"12","author":"Casiraghi","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"B8-20230120","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1634\/stemcells.2007-0795","article-title":"Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice.","volume":"26","author":"Morigi","year":"2008","journal-title":"Stem Cells"},{"key":"B9-20230120","first-page":"1035","article-title":"Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury.","volume":"14","author":"Herrera","year":"2004","journal-title":"Int J Mol Med"},{"key":"B10-20230120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/SHK.0000000000000080","article-title":"Mesenchymal stem cells ameliorate sepsis-associated acute kidney injury in mice.","volume":"41","author":"Luo","year":"2014","journal-title":"Shock"},{"key":"B11-20230120","doi-asserted-by":"crossref","first-page":"F31","DOI":"10.1152\/ajprenal.00007.2005","article-title":"Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms.","volume":"289","author":"T\u00f6gel","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"B12-20230120","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1172\/JCI22593","article-title":"Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells.","volume":"115","author":"Duffield","year":"2005","journal-title":"J Clin Invest"},{"key":"B13-20230120","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.1523-1755.2005.00573.x","article-title":"Administered mesenchymal stem cells enhance recovery from ischemia\/reperfusion-induced acute renal failure in rats.","volume":"68","author":"Lange","year":"2005","journal-title":"Kidney Int"},{"key":"B14-20230120","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3109\/0886022X.2010.494803","article-title":"Repeated administration of bone marrow-derived mesenchymal stem cells improved the protective effects on a remnant kidney model.","volume":"32","author":"Lee","year":"2010","journal-title":"Ren Fail"},{"key":"B15-20230120","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1002\/stem.214","article-title":"Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model.","volume":"27","author":"Semedo","year":"2009","journal-title":"Stem Cells"},{"key":"B16-20230120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/stem.1263","article-title":"Mesenchymal stem cells and endothelial progenitor cells decrease renal injury in experimental swine renal artery stenosis through different mechanisms.","volume":"31","author":"Zhu","year":"2013","journal-title":"Stem Cells"},{"key":"B17-20230120","doi-asserted-by":"crossref","first-page":"17438","DOI":"10.1073\/pnas.0608249103","article-title":"Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD\/scid mice.","volume":"103","author":"Lee","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B18-20230120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bbmt.2008.01.006","article-title":"Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.","volume":"14","author":"Ezquer","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"B19-20230120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.diabres.2014.01.011","article-title":"Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stress.","volume":"104","author":"Lv","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"B20-20230120","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.diabres.2012.09.034","article-title":"Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action.","volume":"98","author":"Park","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"B21-20230120","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/cmi.2008.52","article-title":"Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL\/lpr mice.","volume":"5","author":"Zhou","year":"2008","journal-title":"Cell Mol Immunol"},{"key":"B22-20230120","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1002\/art.27560","article-title":"Interferon-\u03b3-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.","volume":"62","author":"Schena","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B23-20230120","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/stem.68","article-title":"Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans.","volume":"27","author":"Sun","year":"2009","journal-title":"Stem Cells"},{"key":"B24-20230120","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood"},{"key":"B25-20230120","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1182\/blood-2004-09-3696","article-title":"Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells.","volume":"105","author":"Glennie","year":"2005","journal-title":"Blood"},{"key":"B26-20230120","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1182\/blood-2002-07-2104","article-title":"Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.","volume":"101","author":"Krampera","year":"2003","journal-title":"Blood"},{"key":"B27-20230120","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3324\/haematol.12857","article-title":"The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes.","volume":"93","author":"Tabera","year":"2008","journal-title":"Haematologica"},{"key":"B28-20230120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2249.2009.03874.x","article-title":"Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells.","volume":"156","author":"English","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"B29-20230120","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.imlet.2007.10.002","article-title":"Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation.","volume":"115","author":"English","year":"2008","journal-title":"Immunol Lett"},{"key":"B30-20230120","doi-asserted-by":"crossref","first-page":"17384","DOI":"10.1073\/pnas.1103650108","article-title":"Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells.","volume":"108","author":"Chiesa","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B31-20230120","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/stem.2369","article-title":"Mesenchymal stromal cells induce peculiar alternatively activated macrophages capable of dampening both innate and adaptive immune responses.","volume":"34","author":"Chiossone","year":"2016","journal-title":"Stem Cells"},{"key":"B32-20230120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","article-title":"Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production.","volume":"15","author":"N\u00e9meth","year":"2009","journal-title":"Nat Med"},{"key":"B33-20230120","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/14653249.2011.613927","article-title":"Original article anti-oxidant pathways are stimulated by mesenchymal stromal cells in renal repair after ischemic injury.","volume":"14","author":"Liu","year":"2012","journal-title":"Cytotherapy"},{"issue":"8B","key":"B34-20230120","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1111\/j.1582-4934.2008.00641.x","article-title":"VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury.","volume":"13","author":"T\u00f6gel","year":"2009","journal-title":"J Cell Mol Med"},{"key":"B35-20230120","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1089\/ten.tea.2008.0359","article-title":"Adipose stromal cells stimulate angiogenesis via promoting progenitor cell differentiation, secretion of angiogenic factors, and enhancing vessel maturation.","volume":"15","author":"Rubina","year":"2009","journal-title":"Tissue Eng Part A"},{"key":"B36-20230120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1479-5876-9-51","article-title":"Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction.","volume":"9","author":"Chen","year":"2011","journal-title":"J Transl Med"},{"key":"B37-20230120","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3727\/096368912X640448","article-title":"Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats.","volume":"21","author":"Alfarano","year":"2012","journal-title":"Cell Transplant"},{"key":"B38-20230120","doi-asserted-by":"crossref","first-page":"e33115","DOI":"10.1371\/journal.pone.0033115","article-title":"Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury.","volume":"7","author":"Bruno","year":"2012","journal-title":"PLoS One"},{"key":"B39-20230120","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12865-015-0135-7","article-title":"Mesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantation.","volume":"16","author":"Stenger","year":"2015","journal-title":"BMC Immunol"},{"key":"B40-20230120","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1097\/TP.0000000000001029","article-title":"The potential of mesenchymal stromal cells as treatment for severe steroid-refractory acute graft-versus-host disease: A critical review of the literature.","volume":"100","author":"Munneke","year":"2016","journal-title":"Transplantation"},{"key":"B41-20230120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/intimm\/dxx008","article-title":"Mesenchymal stromal cells and autoimmunity.","volume":"29","author":"Pistoia","year":"2017","journal-title":"Int Immunol"},{"key":"B42-20230120","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/ndt\/gfs556","article-title":"Mesenchymal stem cells and kidney repair.","volume":"28","author":"Morigi","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"B43-20230120","first-page":"393","article-title":"The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells.","volume":"3","author":"Friedenstein","year":"1970","journal-title":"Cell Tissue Kinet"},{"key":"B44-20230120","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement.","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"B45-20230120","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00109-012-0915-y","article-title":"Mesenchymal stromal cells (MSCs): Science and f(r)iction.","volume":"90","author":"Bieback","year":"2012","journal-title":"J Mol Med (Berl)"},{"key":"B46-20230120","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/14653240701584578","article-title":"UC blood-derived mesenchymal stromal cells: An overview.","volume":"9","author":"Flynn","year":"2007","journal-title":"Cytotherapy"},{"key":"B47-20230120","doi-asserted-by":"crossref","first-page":"461718","DOI":"10.1155\/2012\/461718","article-title":"Mesenchymal stem cells isolated from adipose and other tissues: Basic biological properties and clinical applications.","volume":"2012","author":"Orbay","year":"2012","journal-title":"Stem Cells Int"},{"key":"B48-20230120","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.108.175943","article-title":"Aging and disease as modifiers of efficacy of cell therapy.","volume":"102","author":"Dimmeler","year":"2008","journal-title":"Circ Res"},{"key":"B49-20230120","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nbt.2816","article-title":"Mesenchymal stem cells: Immune evasive, not immune privileged.","volume":"32","author":"Ankrum","year":"2014","journal-title":"Nat Biotechnol"},{"key":"B50-20230120","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1002\/stem.1452","article-title":"Concise review: Adult mesenchymal stromal cell therapy for inflammatory diseases: How well are we joining the dots?","volume":"31","author":"Griffin","year":"2013","journal-title":"Stem Cells"},{"key":"B51-20230120","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fimmu.2012.00253","article-title":"Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development.","volume":"3","author":"Ancans","year":"2012","journal-title":"Front Immunol"},{"key":"B52-20230120","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1681\/ASN.2004121113","article-title":"Viral infection in the renal transplant recipient.","volume":"16","author":"Kotton","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B53-20230120","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nrneph.2010.102","article-title":"Malignancy after renal transplantation: The role of immunosuppression.","volume":"6","author":"Rama","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"B54-20230120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/tri.12413","article-title":"Cardiovascular morbidity and mortality after kidney transplantation.","volume":"28","author":"Stoumpos","year":"2015","journal-title":"Transpl Int"},{"key":"B55-20230120","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/dme.12534","article-title":"New-onset diabetes after renal transplantation.","volume":"31","author":"Tufton","year":"2014","journal-title":"Diabet Med"},{"key":"B56-20230120","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2215\/CJN.04950610","article-title":"Autologous mesenchymal stromal cells and kidney transplantation: A pilot study of safety and clinical feasibility.","volume":"6","author":"Perico","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B57-20230120","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/tri.12132","article-title":"Mesenchymal stromal cells and kidney transplantation: Pretransplant infusion protects from graft dysfunction while fostering immunoregulation.","volume":"26","author":"Perico","year":"2013","journal-title":"Transpl Int"},{"key":"B58-20230120","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/jama.2012.316","article-title":"Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: A randomized controlled trial.","volume":"307","author":"Tan","year":"2012","journal-title":"JAMA"},{"key":"B59-20230120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5966\/sctm.2012-0114","article-title":"Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: Results of a phase I study.","volume":"2","author":"Reinders","year":"2013","journal-title":"Stem Cells Transl Med"},{"key":"B60-20230120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/nep.12338","article-title":"Safety and efficacy of autologous mesenchymal stromal cells transplantation in patients undergoing living donor kidney transplantation: A pilot study.","volume":"20","author":"Mudrabettu","year":"2015","journal-title":"Nephrology (Carlton)"},{"key":"B61-20230120","doi-asserted-by":"crossref","first-page":"12089","DOI":"10.18632\/oncotarget.7725","article-title":"Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: A prospective, non-randomized study.","volume":"7","author":"Pan","year":"2016","journal-title":"Oncotarget"},{"key":"B63-20230120","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1111\/ajt.13480","article-title":"Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients.","volume":"15","author":"Newell","year":"2015","journal-title":"Am J Transplant"},{"key":"B64-20230120","doi-asserted-by":"crossref","first-page":"602597","DOI":"10.1155\/2015\/602597","article-title":"Mesenchymal stromal cell therapy in ischemia\/reperfusion injury.","volume":"2015","author":"Rowart","year":"2015","journal-title":"J Immunol Res"},{"key":"B65-20230120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2017.03.001","article-title":"Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study.","volume":"67","author":"Detry","year":"2017","journal-title":"J Hepatol"},{"key":"B66-20230120","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1056\/NEJMc1213779","article-title":"HLA-mismatched renal transplantation without maintenance immunosuppression.","volume":"368","author":"Kawai","year":"2013","journal-title":"N Engl J Med"},{"key":"B67-20230120","doi-asserted-by":"crossref","first-page":"124ra28","DOI":"10.1126\/scitranslmed.3003509","article-title":"Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.","volume":"4","author":"Leventhal","year":"2012","journal-title":"Sci Transl Med"},{"key":"B68-20230120","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.ajkd.2012.08.034","article-title":"Kidney protection and regeneration following acute injury: Progress through stem cell therapy.","volume":"60","author":"T\u00f6gel","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"B69-20230120","first-page":"31","article-title":"Initial report on a phase I clinical trial: Prevention and treatment of post-operative acute kidney injury with allogeneic mesenchymal stem cells in patients who required on-pump cardiac surgery.","volume":"1","author":"Gooch","year":"2008","journal-title":"Cell Ther Transplant"},{"key":"B72-20230120","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1172\/JCI27699","article-title":"Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes.","volume":"116","author":"Remuzzi","year":"2006","journal-title":"J Clin Invest"},{"key":"B73-20230120","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1681\/ASN.2007090970","article-title":"Role of remission clinics in the longitudinal treatment of CKD.","volume":"19","author":"Ruggenenti","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B74-20230120","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1681\/ASN.2012040390","article-title":"Mechanisms and treatment of CKD.","volume":"23","author":"Ruggenenti","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B75-20230120","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S2213-8587(15)00094-7","article-title":"Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes.","volume":"3","author":"Porrini","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B76-20230120","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/ndt\/gfu411","article-title":"Diabetic nephropathy: Landmark clinical trials and tribulations.","volume":"31","author":"Chan","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B77-20230120","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.2337\/dc14-2830","article-title":"Allogeneic mesenchymal precursor cells in type 2 diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study.","volume":"38","author":"Skyler","year":"2015","journal-title":"Diabetes Care"},{"key":"B78-20230120","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ebiom.2016.09.011","article-title":"Allogeneic mesenchymal precursor cells (MPC) in diabetic nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study.","volume":"12","author":"Packham","year":"2016","journal-title":"EBioMedicine"},{"key":"B79-20230120","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ki.2013.47","article-title":"The GFR and GFR decline cannot be accurately estimated in type 2 diabetics.","volume":"84","author":"Gaspari","year":"2013","journal-title":"Kidney Int"},{"key":"B80-20230120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/dom.12583","article-title":"Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes.","volume":"18","author":"Schievink","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"B81-20230120","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13287-017-0557-7","article-title":"Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients.","volume":"8","author":"Makhlough","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"B82-20230120","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1681\/ASN.2017020151","article-title":"Autologous mesenchymal stem cells increase cortical perfusion in renovascular disease.","volume":"28","author":"Saad","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B83-20230120","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/ard.2009.123463","article-title":"Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: A pilot clinical study.","volume":"69","author":"Liang","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B84-20230120","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/art.27548","article-title":"Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus.","volume":"62","author":"Sun","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B85-20230120","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.3727\/096368911X582769c","article-title":"Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 Years of experience.","volume":"22","author":"Wang","year":"2013","journal-title":"Cell Transplant"},{"key":"B86-20230120","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/ar4520","article-title":"Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: A multicenter clinical study.","volume":"16","author":"Wang","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B87-20230120","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s10067-014-2754-4","article-title":"Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy.","volume":"33","author":"Gu","year":"2014","journal-title":"Clin Rheumatol"},{"key":"B88-20230120","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1136\/annrheumdis-2017-211073","article-title":"A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis.","volume":"76","author":"Deng","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B89-20230120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12015-011-9345-4","article-title":"Multipotent mesenchymal stromal cell therapy and risk of malignancies.","volume":"9","author":"Casiraghi","year":"2013","journal-title":"Stem Cell Rev"},{"key":"B90-20230120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000047856","article-title":"The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion.","volume":"169","author":"Gao","year":"2001","journal-title":"Cells Tissues Organs"},{"key":"B91-20230120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fimmu.2012.00297","article-title":"Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion.","volume":"3","author":"Eggenhofer","year":"2012","journal-title":"Front Immunol"},{"key":"B92-20230120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13287-015-0271-2","article-title":"Biodistribution, migration and homing of systemically applied mesenchymal stem\/stromal cells.","volume":"7","author":"Leibacher","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"B93-20230120","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1097\/01.ASN.0000128974.07460.34","article-title":"Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure.","volume":"15","author":"Morigi","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"B94-20230120","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev.med.59.061506.154239","article-title":"Mesenchymal stem cells in acute kidney injury.","volume":"59","author":"Humphreys","year":"2008","journal-title":"Annu Rev Med"},{"key":"B95-20230120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/nyas.12815","article-title":"The immunomodulatory function of mesenchymal stem cells: Mode of action and pathways.","volume":"1351","author":"Uccelli","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"B96-20230120","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1200\/JCO.2000.18.2.307","article-title":"Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy.","volume":"18","author":"Ko\u00e7","year":"2000","journal-title":"J Clin Oncol"},{"key":"B97-20230120","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.nucmedbio.2011.03.008","article-title":"In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis.","volume":"38","author":"Gholamrezanezhad","year":"2011","journal-title":"Nucl Med Biol"},{"key":"B98-20230120","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/leu.2011.108","article-title":"Mesenchymal stromal cell \u2018licensing\u2019: A multistep process.","volume":"25","author":"Krampera","year":"2011","journal-title":"Leukemia"},{"key":"B99-20230120","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/stem.698","article-title":"Pretreatment with interferon-\u03b3 enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis.","volume":"29","author":"Duijvestein","year":"2011","journal-title":"Stem Cells"},{"key":"B100-20230120","doi-asserted-by":"crossref","first-page":"e10088","DOI":"10.1371\/journal.pone.0010088","article-title":"A new mesenchymal stem cell (MSC) paradigm: Polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.","volume":"5","author":"Waterman","year":"2010","journal-title":"PLoS One"},{"key":"B101-20230120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1634\/stemcells.2007-0454","article-title":"Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling.","volume":"26","author":"Liotta","year":"2008","journal-title":"Stem Cells"},{"key":"B102-20230120","article-title":"Extracellular membrane vesicles from umbilical cord blood-derived MSC protect against ischemic acute kidney injury, a feature that is lost after inflammatory conditioning [published online ahead of print December 10, 2013].","author":"Kilpinen","journal-title":"J Extracell Vesicles"},{"key":"B103-20230120","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1089\/scd.2017.0025","article-title":"Intrinsic mesenchymal stem cell dysfunction in diabetes mellitus: Implications for autologous cell therapy.","volume":"26","author":"van de Vyver","year":"2017","journal-title":"Stem Cells Dev"},{"key":"B104-20230120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcyt.2016.09.008","article-title":"The exciting prospects of new therapies with mesenchymal stromal cells.","volume":"19","author":"Prockop","year":"2017","journal-title":"Cytotherapy"},{"key":"B105-20230120","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.bbmt.2011.07.023","article-title":"Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy.","volume":"18","author":"von Bahr","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"B106-20230120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jcyt.2012.10.002","article-title":"The mesenchymal stromal cells dilemma--Does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?","volume":"15","author":"Galipeau","year":"2013","journal-title":"Cytotherapy"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201802000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:30:07Z","timestamp":1786131007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201802000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,30]]},"references-count":103,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2017070781","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,30]]}}}